Inhibition of NF-κB-Mediated Proinflammatory Transcription by Ru(II) Complexes of Anti-Angiogenic Ligands in Triple-Negative Breast Cancer

Nuclear factor kappa beta (NF-κB) plays a pivotal role in breast cancer, particularly triple-negative breast cancer, by promoting inflammation, proliferation, epithelial-mesenchymal transition, metastasis, and drug resistance. Upregulation of NF-κB boosts vascular endothelial growth factor (VEGF) expression, assisting angiogenesis. The Ru(II) complexes of methyl- and dimethylpyrazolyl-benzimidazole N,N donors inhibit phosphorylation of ser536 in p65 and translocation of the NF-κB heterodimer (p50/p65) to the nucleus, disabling transcription to upregulate inflammatory signaling. The methyl- and dimethylpyrazolyl-benzimidazole inhibit VEGFR2 phosphorylation at Y1175, disrupting downstream signaling through PLC-γ and ERK1/2, ultimately suppressing Ca(II)-signaling. Partial release of the antiangiogenic ligand in a reactive oxygen species-rich environment is possible as per our observation to inhibit both NF-κB and VEGFR2 by the complexes. The complexes are nontoxic to zebrafish embryos up to 50 μM, but the ligands show strong in vivo antiangiogenic activity at 3 μM during embryonic growth in Tg(fli1:GFP) zebrafish but no visible effect on the adult phase.

The Ionic Organic Cage: An Effective and Recyclable Testbed for Catalytic CO2 Transformation

Porous organic cages (POC) are a class of relatively new molecular porous materials, whose concept was raised in 2009 by Cooper’s group and has rarely been directly used in the area of organic catalysis. In this contribution, a novel ionic quasi-porous organic cage (denoted as Iq-POC), a quaternary phosphonium salt, was easily synthesized through dynamic covalent chemistry and a subsequent nucleophilic addition reaction. Iq-POC was applied as an effective nucleophilic catalyst for the cycloaddition reaction of CO2 and epoxides. Owing to the combined effect of the relatively large molecular weight (compared with PPh3+I−) and the strong polarity of Iq-POC, the molecular catalyst Iq-POC displayed favorable heterogeneous nature (i.e., insolubility) in this catalytic system. Therefore, the Iq-POC catalyst could be easily separated and recycled by simple centrifugation method, and the catalyst could be reused five times without obvious loss of activity. The molecular weight augmentation route in this study (from PPh3+I− to Iq-POC) provided us a “cage strategy” of designing separable and recyclable molecular catalysts.

Organic cage supported metal nanoparticles for applications

Porous shape-persistent organic cages can anchor metal nanoparticles either inside the cavity or in the external cavity generated through self-assembly. The size of these nanoparticles range from 1-2 nm depending upon the host and can be controlled within a narrow size distribution. The nanoparticles thus formed are quite stable as they are segregated efficiently preventing their association and eventual precipitation. These fine nanoparticles are found to be quite effective in catalyzing a number of organic transformations besides showing interesting emission properties.

Selective Release of Doxorubicin from Cucurbit[8]uril Stabilized Gold Supra-Pyramid Host at pH of Small Intestine

Gold supra-pyramid structures were obtained by the addition of acidic solution of cucurbit[8]uril (CB[8]) to an aqueous solution of citrate stabilized gold nanoparticles (AuNP). The reaction resulted in the precipitation of supra-pyramid from the solution after just 1 min of shaking. Microscopic images confirmed formation of the supra-pyramid. The stepwise structural transformation towards the supra-pyramid was examined with variable concentrations of CB[8] to AuNP solution. Anionic counter parts of these acids (Br^- , NO₃ ^- , SO₄ ^2- and Cl^- ) controlled the size of the synthesized supra-pyramids. These supra-pyramid hosts showed uptake of three anticancer drugs: oral drugs etoposide, prednisolone and intravenous drug doxorubicin. Releases of drugs from these hosts were emulated at acidic stomach pH, basic small intestinal pH and in the presence of human serum albumin (HSA). The specific release of doxorubicin was confirmed at small intestinal pH 7.4. Poor release of drugs in presence of CB[8] specific guest 1-adamantanamine confirmed the role of the supra-pyramid as the exclusive host. The release of doxorubicin from the supra-pyramid at pH 7.4 was confirmed by fluorescence microscopic imaging with prostate cancer DU-145 cell line.